KLRK1 and neoplasm: CAR molecules that were obtained by fusion of the full-length NKG2D with the CD3z cytoplasmic region together with endogenous DAP10 costimulation, were demonstrated to react with NKG2DL-expressing tumor cells through cytokine and chemokine production, thus enhancing cytotoxicity [96].